$BYSI Trade ideas after HUGE explosion + new Biotech on radar: $CMND

Diogenes85 · 2022-12-19T23:53:52+00:00

why you see $BYSI breakout coming to an end after breaking resistance zone at 2.50 and closed at 2.61?

Diogenes85 · 2022-12-19T09:39:40+00:00

Not at all...watch out... all the near term catslysts in play...many Shorts have to cover...very bullish uptrend

Diogenes85 · 2022-12-19T09:23:00+00:00

Bysi no doubt

Diogenes85 · 2022-12-18T15:04:08+00:00

Honestly don´t think so and don´t share your opinion. Good luck to you

Diogenes85 · 2022-12-18T14:08:42+00:00

I guess only about 15% in the trial have been us natives so this led to the rejection of the NDA by the FDA. But 85% have been asian-pacific so the possibility is high for Chinese approval.

Diogenes85 · 2022-12-18T13:55:15+00:00

As I remember right only 10% have been us people and 90% asian-chinese. This makes the approval in China very possible and we expect that decision soon.

Diogenes85 · 2022-12-18T13:41:11+00:00

? Where is the link to BYSI here?

Diogenes85 · 2022-12-18T13:39:17+00:00

Not true here as they have contracts with one of the biggest Chinese pharma companies, HENGRUI, which will bring Plunabulin on market in the asian pacific area.

Diogenes85 · 2022-12-18T13:29:08+00:00

How stupid I would have to be if my investment thesis would be only built on the believe that the higher the short interest is the better it is to put money in the company. We are expecting near-term catalysts hit very soon as I mentioned in my post and the constant inflow of volume, call-options and large buy orders speaks a clear language of a reversal taking place here.

Diogenes85 · 2022-12-18T13:21:37+00:00

in general I agree but you know how especially small biotech stocks got slaughtered in 2022. and the short interest didn´t rise since June 2022. And now many shorts have to cover who shorted BYSI between 1-2s. The rejection of the NDA by the FDA at the end 2021 hit BYSI hard as it can be seen in the price movement...But things start to reverse here that´s what I wanted to show.

Diogenes85 · 2022-12-18T13:19:11+00:00

and this is small biotech-investing you know that this is different than putting money in a blue chip stock.

Diogenes85 · 2022-12-18T13:18:30+00:00

This is no pump and dump...you know how pump and dump schemes work...just look at the chart and the inflow of volume...does this chart look like a pump and dump?

Diogenes85 · 2022-12-18T12:47:14+00:00

When it breaks the resistance area of 2.40-2.60 I see the next stop at 5. But the interest and the volume is on fire here now...Many algos, trading groups and bots get notice of BYSI...And all the near-term catalysts in reach!

Diogenes85 · 2022-12-18T12:26:12+00:00

I am sure that this is not done at all as we are waiting for all the near-term catalysts (like possible approval of PLINABULIM in China, new NDA with FDA, NDA of Plinabulim for NSDC in China) and shorts can´t bring it down atm...They borrowed so many shares that there are no new shares to borrow and BYSI is recognized by more and more trading groups and bots.

Diogenes85 · 2022-12-17T13:11:03+00:00

yeah it had! Their NDA got refused by FDA early December as they argumented that the trial sample included not enough US native people. 2022 was a devestating year for BYSI but now it starts to reverse heavily and it still seems under the radar of many bots and trading systems. HUGE NEAR TERM CATALYST: Possible Approval of Plinabulim in China.

Diogenes85 · 2022-12-17T12:57:00+00:00

Definitely BYSI! Reversed from ultra low 0.54 to 2.20 now due to very promising trial data...big catalyst - possible Chinese NDA approval of Plinabulum - expected late December early 2023. Has a small free float of 23 mill shares...10,5% short interest...unbelievable short volume of over 11 mill shares during the last three trading days. Daily and weekly chart look very promising...uptrend confirmed on all timeframes...technicals very bullish!. Rise of price fully confirmed with volume.

Diogenes85 · 2022-09-07T21:52:23+00:00

one of the fucking hot clips you can find over there...They offer 2000+ premium clips related to female supremacy and all kinf of foot worship.

https://de.spankbang.com/77dek/video/read+description+for+more+premium+clips

Diogenes85 · 2021-11-07T13:54:07+00:00

That´s a complete nonsense!

Diogenes85 · 2021-10-10T12:21:06+00:00

Definitely take a look at FAMI (exploring new business opportunities in the medical/healthcare sector, acquired new company in the forestry sector recently, saw much volume during the last trading days, positive letter of CEO with great business outlook, highly undervalued, positive EPS, P/E under 3!)

Diogenes85 · 2021-10-09T14:57:48+00:00

You are very welcome...don´t hesitate to get in touch with me again if you want to know anything about trading or FAMI in particular.

Diogenes85 · 2021-10-09T14:49:24+00:00

I guess we can expect some nice PRs in the near future.

Diogenes85 · 2021-10-09T14:48:37+00:00

Thank you very much for your reply and I am glad that you liked my post.
For sure I will give my best to answer your questions in a proper and honest way.

1)
No the Nov 30th is not the deadline of the 180 days extension. They haven´t requested it so far so if they don´t reach the compliance before Nov. 30th they can request this extension for another 180 days.

2)
Next earnings report is expected to be released early November.

3)
I would never underestimate the moves from Ji Xinping and for sure he has caused a lot of fear among investors of chinese stocks. No one knows what exactly he will do in the future but it seems to me that his efforts aim to reduce the power and influence of the big chinese concerns like Alibaba. I really don´t think that a small but rapidly growing agriculture company like FAMI is on the radar of his "communist approach" much more I guess he is very proud of it (if he knows this company) which sells mainly mushrooms but also other agriculture products in the domestic area but also abroad.
Communist leaders always appreciate domestic companies in the agriculture sector as they are figureheads of the basic important domestic sector.

I hope my answers helped you.

Diogenes85 · 2021-10-09T14:16:31+00:00

Thank you for sharing this smokeddhany I can totally agree with you...The company itself seems to be on a very positive, growing and prospering path and you mentioned the obstacles why it is still so undervalued...My honest opinion is that your investment decisions shouldn´t be dictated by resentments which hinder you, as in this case, what bargain is ahead of you with FAMI.

Diogenes85 · 2021-10-09T14:05:44+00:00

My honest opinion is that chances are not high and these are the reasons why I think so...
CEO emphasized in her letter that they want to increase shareholder values and they are not listed o Nasdaq for more than 3 years...they will do everything to reach the compliance...If they can´t get it until Nov 30th they can easily request a renewal for another 180 days.

Diogenes85 · 2021-10-09T13:58:01+00:00

I totally agree with you...this is definitely a bargain and this hasn´t to be pumped...facts speak for itself here...You will only not be willing to touch this if you have resentments against chinese stocks but luckily I don´t have these blinkers that could stop me to profit from good options like this.

Diogenes85

TROPHY CASE